EurekAlert! -
30 Aug 2015 06:00
(European Society of Cardiology) Patients with atrial fibrillation who receive antithrombotic management according to ESC guidelines have better outcomes than those who do not, according to one year follow up results from the ESC's EORP-AF Pilot General Registry presented today at ESC Congress 2015 and published online in Europace.
Share this Article